Iovance Biotherapeutics, Inc.
US ˙ NasdaqGM ˙ US4622601007

SecurityIOVA / Iovance Biotherapeutics, Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Amalgamated Bank closes position in IOVA / Iovance Biotherapeutics, Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 0 shares of Iovance Biotherapeutics, Inc. (US:IOVA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 9,661 shares of Iovance Biotherapeutics, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -9,661 -100.00 0 0.0000
2026-02-05 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 9,661 151 1.59 0 0.0002
2025-10-29 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 9,510 0 0.00 0 0.0002
2025-08-04 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 9,510 0 0.00 0 0.0001
2025-04-25 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 9,510 1,179 14.15 0 0.0003
2025-02-04 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,331 0 0.00 0 0.0005
2024-10-30 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,331 0 0.00 0 0.0006
2024-08-12 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,331 263 3.26 0 0.0006
2024-04-23 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,068 -12,868 -61.46 0 0.0010
2024-02-06 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 20,936 -1,370 -6.14 0 0.0014
2023-11-08 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 22,306 4,434 24.81 0 0.0009
2023-08-11 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 17,872 2,321 14.93 0 0.0010
2023-05-02 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 15,551 -3,682 -19.14 0 0.0008
2023-02-10 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 19,233 0 0.00 0 -100.00 0.0011
2022-11-09 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 19,233 187 0.98 184 -12.38 0.0018
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 19,046 -9,801 -33.98 210 -56.25 0.0020
2022-08-25 2022-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 28,847 633 2.24 480 -10.95 0.0037
2022-06-30 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 28,847 633 480 0.0038
2022-02-15 2021-12-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 28,214 1,514 5.67 539 -18.09 0.0040
2022-02-15 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 28,214 1,514 539 0.0040
2021-10-29 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 26,700 -1,090 -3.92 658 -8.99 0.0056
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 27,790 2,158 8.42 723 -10.96 0.0058
2021-05-13 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 25,632 -2,234 -8.02 812 -37.20 0.0304
2021-02-12 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 27,866 -6 -0.02 1,293 40.85 0.0490
2020-10-30 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 27,872 -178 -0.63 918 19.22 0.0399
2020-08-10 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 28,050 6,950 32.94 770 21.84 0.0356
2020-05-13 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 21,100 -934 -4.24 632 3.61 0.0155
2020-02-13 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 22,034 1,737 8.56 610 65.31 0.0112
2019-11-13 2019-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 20,297 -262 -1.27 369 -26.79 0.0078
2019-08-14 2019-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 20,559 5,294 34.68 504 247.59 0.0118
2019-05-15 2019-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 15,265 631 4.31 145 11.54 0.0035
2019-02-15 2018-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 14,634 14,634 130 0.0037
2018-11-14 2018-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -12,579 -100.00 0 -100.00
2018-07-18 2018-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 12,579 12,579 161 0.0039
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.